Inmed pharmaceuticals reports second quarter fiscal 2022 financial results and provides business update

Vancouver, british columbia, feb. 14, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced financial results for the second quarter of fiscal year 2022 which ended december 31, 2021.

INM Ratings Summary

INM Quant Ranking